BioNTech SE

$150.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$10.82 (+7.69%) Today
-$1.34 (-0.88%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell BioNTech SE and other stocks, options, and ETFs commission-free!

About BNTX

BioNTech SE American Depositary Share, also called BioNTech SE, is a next-generation immunotherapy company, which treats cancer and other serious diseases. It exploits an array of discovery and therapeutic drug platforms for the development of novel biopharmaceuticals.

CEO
Ugur Sahin
Employees
1,941
Headquarters
Mainz, Rheinland-Pfalz
Founded
2008
Market Cap
33.72B
Price-Earnings Ratio
1.91K
Dividend Yield
—
Average Volume
2.67M
High Today
$152.32
Low Today
$141.50
Open Price
$141.50
Volume
4.62M
52 Week High
$152.32
52 Week Low
$38.88

BNTX Earnings

-$1.03
-$0.06
$0.90
$1.87
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Available May 10, Pre-Market

You May Also Like

PSJ
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure